AAPL349.73+1.51 (+0.43%) ▲|ABBV283.49-1.45 (-0.51%) ▼|ABT102.40-0.12 (-0.11%) ▼|ACN245.90-12.84 (-4.96%) ▼|ADBE266.96-3.59 (-1.33%) ▼|AMAT376.93+1.35 (+0.36%) ▲|AMD516.69+8.76 (+1.72%) ▲|AMGN440.77-6.51 (-1.46%) ▼|AMT192.35+10.78 (+5.94%) ▲|AMZN248.56-1.82 (-0.73%) ▼|AVGO324.87+1.63 (+0.50%) ▲|AXP315.83-9.34 (-2.87%) ▼|BA185.04-2.51 (-1.34%) ▼|BAC50.68-0.40 (-0.78%) ▼|BKNG157.29-3.81 (-2.37%) ▼|BLK1,121.22-16.08 (-1.41%) ▼|BMY61.77-1.23 (-1.95%) ▼|BNY144.11-1.21 (-0.83%) ▼|BRK-B545.91-1.07 (-0.19%) ▼|C120.89-1.62 (-1.32%) ▼|CAT683.80-20.26 (-2.88%) ▼|CL94.85-2.55 (-2.61%) ▼|CMCSA22.81-0.03 (-0.13%) ▼|COF200.80-2.64 (-1.30%) ▼|COP150.53+4.90 (+3.36%) ▲|COST1,010.61-7.60 (-0.75%) ▼|CRM245.87-4.43 (-1.77%) ▼|CSCO105.68+0.79 (+0.75%) ▲|CVS93.66-0.82 (-0.87%) ▼|CVX230.56+3.88 (+1.71%) ▲|DE635.53-8.10 (-1.26%) ▼|DHR226.74-3.01 (-1.31%) ▼|DIS112.11-1.02 (-0.90%) ▼|DUK124.40-1.01 (-0.80%) ▼|EMR158.70-1.59 (-0.99%) ▼|FDX296.83-7.10 (-2.33%) ▼|GD346.85-3.95 (-1.12%) ▼|GE284.21-9.33 (-3.18%) ▼|GEV807.01-20.41 (-2.47%) ▼|GILD156.36-0.84 (-0.53%) ▼|GM75.19-2.02 (-2.62%) ▼|GOOG320.81+0.05 (+0.01%) ▲|GOOGL323.99-0.23 (-0.07%) ▼|GS882.41-8.89 (-1.00%) ▼|HD319.03-8.70 (-2.65%) ▼|HON212.59-5.72 (-2.62%) ▼|IBM252.08-0.03 (-0.01%) ▼|INTC86.50+1.01 (+1.18%) ▲|INTU349.29-5.62 (-1.58%) ▼|ISRG452.05+8.20 (+1.85%) ▲|JNJ263.59-4.03 (-1.50%) ▼|JPM331.33-5.21 (-1.55%) ▼|KO93.27-2.08 (-2.18%) ▼|LIN505.84-4.52 (-0.89%) ▼|LLY1,277.92-28.77 (-2.20%) ▼|LMT593.98+4.07 (+0.69%) ▲|LOW198.83-5.55 (-2.71%) ▼|LRCX227.65-2.51 (-1.09%) ▼|MA623.08-10.14 (-1.60%) ▼|MCD248.54-4.09 (-1.62%) ▼|MDLZ63.93-1.26 (-1.93%) ▼|MDT95.79-0.80 (-0.83%) ▼|META644.37-4.48 (-0.69%) ▼|MMM170.98-4.58 (-2.61%) ▼|MO75.18-0.89 (-1.17%) ▼|MRK144.14-3.10 (-2.10%) ▼|MS181.46-2.52 (-1.37%) ▼|MSFT523.07+1.99 (+0.38%) ▲|MU881.87+25.38 (+2.96%) ▲|NEE81.43-0.48 (-0.58%) ▼|NFLX67.03-0.02 (-0.03%) ▼|NKE37.49-0.83 (-2.17%) ▼|NOW155.52-1.48 (-0.94%) ▼|NVDA212.66+0.45 (+0.21%) ▲|ORCL126.20+0.66 (+0.52%) ▲|PEP135.89-2.94 (-2.12%) ▼|PFE29.90-0.52 (-1.71%) ▼|PG162.04-2.46 (-1.50%) ▼|PLTR194.70-1.50 (-0.76%) ▼|PM201.34-0.40 (-0.20%) ▼|QCOM173.80+0.97 (+0.56%) ▲|RTX190.57-4.14 (-2.13%) ▼|SBUX101.23-0.68 (-0.67%) ▼|SCHW90.31-1.13 (-1.24%) ▼|SO93.14-0.69 (-0.73%) ▼|SPG211.43-0.61 (-0.29%) ▼|T21.53-1.22 (-5.34%) ▼|TMO667.70-8.84 (-1.31%) ▼|TMUS152.48-6.32 (-3.98%) ▼|TSLA372.08-2.51 (-0.67%) ▼|TXN281.50+2.00 (+0.72%) ▲|UBER67.71-1.36 (-1.97%) ▼|UNH421.78-3.21 (-0.75%) ▼|UNP289.88-8.22 (-2.76%) ▼|UPS99.36-2.16 (-2.13%) ▼|USB59.13-0.89 (-1.48%) ▼|V407.29-7.05 (-1.70%) ▼|VZ43.92-1.28 (-2.83%) ▼|WFC82.00-1.01 (-1.22%) ▼|WMT120.23-0.89 (-0.73%) ▼|XOM181.49+3.26 (+1.83%) ▲|AAPL349.73+1.51 (+0.43%) ▲|ABBV283.49-1.45 (-0.51%) ▼|ABT102.40-0.12 (-0.11%) ▼|ACN245.90-12.84 (-4.96%) ▼|ADBE266.96-3.59 (-1.33%) ▼|AMAT376.93+1.35 (+0.36%) ▲|AMD516.69+8.76 (+1.72%) ▲|AMGN440.77-6.51 (-1.46%) ▼|AMT192.35+10.78 (+5.94%) ▲|AMZN248.56-1.82 (-0.73%) ▼|AVGO324.87+1.63 (+0.50%) ▲|AXP315.83-9.34 (-2.87%) ▼|BA185.04-2.51 (-1.34%) ▼|BAC50.68-0.40 (-0.78%) ▼|BKNG157.29-3.81 (-2.37%) ▼|BLK1,121.22-16.08 (-1.41%) ▼|BMY61.77-1.23 (-1.95%) ▼|BNY144.11-1.21 (-0.83%) ▼|BRK-B545.91-1.07 (-0.19%) ▼|C120.89-1.62 (-1.32%) ▼|CAT683.80-20.26 (-2.88%) ▼|CL94.85-2.55 (-2.61%) ▼|CMCSA22.81-0.03 (-0.13%) ▼|COF200.80-2.64 (-1.30%) ▼|COP150.53+4.90 (+3.36%) ▲|COST1,010.61-7.60 (-0.75%) ▼|CRM245.87-4.43 (-1.77%) ▼|CSCO105.68+0.79 (+0.75%) ▲|CVS93.66-0.82 (-0.87%) ▼|CVX230.56+3.88 (+1.71%) ▲|DE635.53-8.10 (-1.26%) ▼|DHR226.74-3.01 (-1.31%) ▼|DIS112.11-1.02 (-0.90%) ▼|DUK124.40-1.01 (-0.80%) ▼|EMR158.70-1.59 (-0.99%) ▼|FDX296.83-7.10 (-2.33%) ▼|GD346.85-3.95 (-1.12%) ▼|GE284.21-9.33 (-3.18%) ▼|GEV807.01-20.41 (-2.47%) ▼|GILD156.36-0.84 (-0.53%) ▼|GM75.19-2.02 (-2.62%) ▼|GOOG320.81+0.05 (+0.01%) ▲|GOOGL323.99-0.23 (-0.07%) ▼|GS882.41-8.89 (-1.00%) ▼|HD319.03-8.70 (-2.65%) ▼|HON212.59-5.72 (-2.62%) ▼|IBM252.08-0.03 (-0.01%) ▼|INTC86.50+1.01 (+1.18%) ▲|INTU349.29-5.62 (-1.58%) ▼|ISRG452.05+8.20 (+1.85%) ▲|JNJ263.59-4.03 (-1.50%) ▼|JPM331.33-5.21 (-1.55%) ▼|KO93.27-2.08 (-2.18%) ▼|LIN505.84-4.52 (-0.89%) ▼|LLY1,277.92-28.77 (-2.20%) ▼|LMT593.98+4.07 (+0.69%) ▲|LOW198.83-5.55 (-2.71%) ▼|LRCX227.65-2.51 (-1.09%) ▼|MA623.08-10.14 (-1.60%) ▼|MCD248.54-4.09 (-1.62%) ▼|MDLZ63.93-1.26 (-1.93%) ▼|MDT95.79-0.80 (-0.83%) ▼|META644.37-4.48 (-0.69%) ▼|MMM170.98-4.58 (-2.61%) ▼|MO75.18-0.89 (-1.17%) ▼|MRK144.14-3.10 (-2.10%) ▼|MS181.46-2.52 (-1.37%) ▼|MSFT523.07+1.99 (+0.38%) ▲|MU881.87+25.38 (+2.96%) ▲|NEE81.43-0.48 (-0.58%) ▼|NFLX67.03-0.02 (-0.03%) ▼|NKE37.49-0.83 (-2.17%) ▼|NOW155.52-1.48 (-0.94%) ▼|NVDA212.66+0.45 (+0.21%) ▲|ORCL126.20+0.66 (+0.52%) ▲|PEP135.89-2.94 (-2.12%) ▼|PFE29.90-0.52 (-1.71%) ▼|PG162.04-2.46 (-1.50%) ▼|PLTR194.70-1.50 (-0.76%) ▼|PM201.34-0.40 (-0.20%) ▼|QCOM173.80+0.97 (+0.56%) ▲|RTX190.57-4.14 (-2.13%) ▼|SBUX101.23-0.68 (-0.67%) ▼|SCHW90.31-1.13 (-1.24%) ▼|SO93.14-0.69 (-0.73%) ▼|SPG211.43-0.61 (-0.29%) ▼|T21.53-1.22 (-5.34%) ▼|TMO667.70-8.84 (-1.31%) ▼|TMUS152.48-6.32 (-3.98%) ▼|TSLA372.08-2.51 (-0.67%) ▼|TXN281.50+2.00 (+0.72%) ▲|UBER67.71-1.36 (-1.97%) ▼|UNH421.78-3.21 (-0.75%) ▼|UNP289.88-8.22 (-2.76%) ▼|UPS99.36-2.16 (-2.13%) ▼|USB59.13-0.89 (-1.48%) ▼|V407.29-7.05 (-1.70%) ▼|VZ43.92-1.28 (-2.83%) ▼|WFC82.00-1.01 (-1.22%) ▼|WMT120.23-0.89 (-0.73%) ▼|XOM181.49+3.26 (+1.83%) ▲|
10.7 C
New York
Friday, October 23, 2026

Tag: treatment

Vital Farms Appoints Billy Cyr to Board of Directors

AUSTIN, Texas, July 02, 2025 (GLOBE NEWSWIRE) -- Vital Farms (Nasdaq: VITL), a Certified B Corporation that offers a range of ethically produced foods nationwide, today announced the appointment of William B. (Billy) Cyr to its board of directors effective July 1, 2025.

Block O’Toole & Murphy Raises Over $1,375,000 for St. Jude’s Hospital at Annual New York City Wine Tasting Event

NEW YORK, July 2, 2025 /PRNewswire/ -- New York personal injury law firm Block O'Toole & Murphy is honored to share that the firm raised...

OXLUMO® (lumasiran injection) Now Reimbursed in Canada For the Treatment of Primary Hyperoxaluria Type 1 (PH1) in Pediatric and Adult Patients

OXLUMO has been shown to significantly reduce urinary oxalate, which drives the progression of PH1 Disease1 MISSISSAUGA, ON, July 2, 2025 /CNW/ - Alnylam Canada ULC...

Lynozyfic™ (linvoseltamab-gcpt) Receives FDA Accelerated Approval for Treatment of Relapsed or Refractory Multiple Myeloma

Lynozyfic is a bispecific antibody directing T cells to kill multiple myeloma cancer cells; multiple myeloma is the second most common blood cancer 

SeekInClarity: Blood-Based Multi-Omics Test Offers Promising Advance in Monitoring Cancer Treatment Response

SAN DIEGO, July 2, 2025 /PRNewswire/ -- A new prospective study published in BMC Cancer demonstrates that a novel blood-based multi-omics test, SeekInClarity, can accurately...

Florida Enacts New Legislation for Faster, More Cost-Effective Septic Tank Removal

TALLAHASSEE, Fla., July 2, 2025 /PRNewswire/ -- Florida has enacted new legislation with a transformative approach to tackling the pollution associated with septic tanks....

Apotex receives Health Canada approval for Aflivu™, a biosimilar to Eylea®, available in pre-filled syringe and vial formats

TORONTO, July 2, 2025 /PRNewswire/ - Apotex Inc. ("Apotex" or the "Company"), the Canadian-based global health company, today announced that Health Canada has approved Aflivu™ (aflibercept),...

Global Fake Image Detection Market Valuation Exceed $ 4.9 Billion by 2030 Dominated by Leading Giants – Microsoft, Google, BioID, Clearview AI, iDenfy, DuckDuckGoose...

NEW DELHI, July 2, 2025 /PRNewswire/ -- In an age where one manipulated image can ignite social unrest, sway elections, or defame reputations, the demand...

Global Fake Image Detection Market Valuation Exceed $ 4.9 Billion by 2030 Dominated by Leading Giants – Microsoft, Google, BioID, Clearview AI, iDenfy, DuckDuckGoose...

NEW DELHI, July 2, 2025 /PRNewswire/ -- In an age where one manipulated image can ignite social unrest, sway elections, or defame reputations, the demand...

Corlines kund Kardium genomför finansiering om 250 miljoner USD för lanseringen av Globe®

Kanadensiska Kardium meddelade under dagen att man genomfört en kapitalrekrytering om 250 miljoner USD för att stödja global kommersialisering av Globe® Pulsed Field System – en banbrytande plattform för behandling av förmaksflimmer med hjälp av behandlingstekniken pulsed field ablation (PFA). Den nu kommunicerade investeringen innebär att Kardium sammantaget attraherat över 350 miljoner USD från externa investerare under de senaste dryga tolv månaderna, vilket tillhör det absoluta toppskiktet i den nordamerikanska medicinteknikindustrin.

Invivyd and Leading Researchers Form SPEAR (Spike Protein Elimination and Recovery) Study Group to Assess the Effects of Monoclonal Antibody Therapy for Long COVID...

Invivyd Forms SPEAR (Spike Protein Elimination and Recovery) Study Group with Researches to Assess Effects of Monoclonal Antibody Therapy for Long COVID

Strobilurin Market worth $6.88 billion by 2030- Exclusive Report by MarketsandMarkets™

DELRAY BEACH, Fla., July 2, 2025 /PRNewswire/ -- The strobilurin market is projected to expand from USD 5.53 billion in 2025 to USD 6.88...

Strobilurin Market worth $6.88 billion by 2030- Exclusive Report by MarketsandMarkets™

DELRAY BEACH, Fla., July 2, 2025 /PRNewswire/ -- The strobilurin market is projected to expand from USD 5.53 billion in 2025 to USD 6.88...

- A word from our sponsors -

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsTreatment